Side-by-side comparison of AI visibility scores, market position, and capabilities
Los Angeles CA commercial real estate marketplace and data platform for buying, selling, and leasing commercial properties; raised $100M+; challenger to CoStar's LoopNet.
CREXi is a commercial real estate marketplace and data platform headquartered in Los Angeles, California. Founded in 2015, the company has raised over $100M in funding and built a comprehensive marketplace where commercial real estate brokers, owners, and investors can list, discover, and transact on commercial properties across the United States. CREXi offers listing services for sales and leasing, auction capabilities for distressed and institutional assets, and an analytics platform providing market data on commercial properties.\n\nCREXi's marketplace aggregates commercial property listings including office, industrial, retail, multifamily, land, and specialty properties, with tools for brokers to manage their listings, track prospect activity, and communicate with interested buyers and tenants. Its data analytics module provides subscribers with access to sales comps, leasing data, market trends, and property records, positioning CREXi as both a transaction marketplace and a research tool for CRE professionals.\n\nCREXi competes directly with CoStar's LoopNet in the commercial property marketplace space, differentiating through its more modern technology platform, competitive pricing for listing subscriptions, and its integrated auction platform. CREXi has gained significant traction among small to mid-size commercial brokerages and independent investors who find LoopNet expensive and less user-friendly. The company's growing listings inventory, particularly in the Sun Belt markets, has made it a meaningful alternative to the dominant CoStar/LoopNet ecosystem for commercial property discovery and marketing.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.